NVS SEC Filings: 8-K, 10-Q, S-3 & 424B – Novartis

Financials

TYPE

HEADLINE

FILED AT

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Feb 4, 2026

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Jan 31, 2025

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Jan 31, 2024

20-F/A

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]

May 15, 2023

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Feb 1, 2023

20-F/A

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]

Apr 26, 2022

News

TYPE

HEADLINE

FILED AT

6-K

Novartis AG Files Form 6-K Including Q3 2026 Financial Report

Oct 27, 2026

6-K

Novartis provides update on delpacibart etedesiran (del-desiran) Phase III HARBOR study for DM1

Sep 8, 2026

6-K

Novartis Announces Topline Results for Phase III Lp(a)HORIZON Trial of Pelacarsen

Sep 4, 2026

6-K

Novartis Announces Positive Phase III Results for Remibrutinib in Relapsing Multiple Sclerosis

Sep 1, 2026

6-K

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Jul 21, 2026

6-K

Novartis Phase I/II Study of Delpacibart Braxlosiran (Del-brax) for FSHD Meets Primary Biomarker Endpoint

Jun 11, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

NEWForm 424B5 - Prospectus [Rule 424(b)(5)]

Nov 9, 2026

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

Mar 17, 2026

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

Mar 16, 2026

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

Nov 4, 2025

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

Nov 3, 2025

424B5

.00 | Offering amount: $1,000,000,000.00 | Bank: Citigroup, Goldman Sachs & Co. LLC, J.P. Morgan, Mizuho, Barclays, HSBC, SOCIETE GENERALE

Sep 17, 2024

Registrations

TYPE

HEADLINE

FILED AT

FWP

NEWForm FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Nov 9, 2026

FWP

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Mar 16, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Feb 4, 2026

S-8 POS

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Jan 16, 2026

S-8 POS

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Jan 16, 2026

S-8 POS

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Jan 16, 2026

Proxies

TYPE

HEADLINE

FILED AT

DFAN14A